Pascal H. Kusters

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Protein-losing enteropathy in marginal zone lymphoma: tissue is the issue.

Protein-losing enteropathy in marginal zone lymphoma: tissue is the issue.

Journal: The Lancet. Haematology

Published: December 22, 2025

Accelerated atherosclerosis associated with immune checkpoint inhibitors: a systematic review and meta-analysis of pre-clinical studies.

Accelerated atherosclerosis associated with immune checkpoint inhibitors: a systematic review and meta-analysis of pre-clinical studies.

Journal: Atherosclerosis

Published: January 13, 2025

Deficiency of germinal center kinase TRAF2 and NCK-interacting kinase (TNIK) in B cells does not affect atherosclerosis.

Deficiency of germinal center kinase TRAF2 and NCK-interacting kinase (TNIK) in B cells does not affect atherosclerosis.

Journal: Frontiers in cardiovascular medicine

Published: February 22, 2023

Immune Checkpoint Inhibitor Therapy Aggravates T Cell-Driven Plaque Inflammation in Atherosclerosis.

Immune Checkpoint Inhibitor Therapy Aggravates T Cell-Driven Plaque Inflammation in Atherosclerosis.

Journal: JACC. CardioOncology

Published: April 30, 2020

Cell-specific and divergent roles of the CD40L-CD40 axis in atherosclerotic vascular disease.

Cell-specific and divergent roles of the CD40L-CD40 axis in atherosclerotic vascular disease.

Journal: Nature communications

Published: February 02, 2020

Antibody-Mediated Inhibition of CTLA4 Aggravates Atherosclerotic Plaque Inflammation and Progression in Hyperlipidemic Mice.

Antibody-Mediated Inhibition of CTLA4 Aggravates Atherosclerotic Plaque Inflammation and Progression in Hyperlipidemic Mice.

Journal: Cells

Published: January 31, 2020

The CD40-CD40L Dyad as Immunotherapeutic Target in Cardiovascular Disease.

The CD40-CD40L Dyad as Immunotherapeutic Target in Cardiovascular Disease.

Journal: Journal of cardiovascular translational research

Published: January 30, 2020

Glucocorticoid-induced tumour necrosis factor receptor family-related protein (GITR) drives atherosclerosis in mice and is associated with an unstable plaque phenotype and cerebrovascular events in humans.

Glucocorticoid-induced tumour necrosis factor receptor family-related protein (GITR) drives atherosclerosis in mice and is associated with an unstable plaque phenotype and cerebrovascular events in humans.

Journal: European heart journal

Published: December 11, 2019

Endothelial TGF-β signalling drives vascular inflammation and atherosclerosis.

Endothelial TGF-β signalling drives vascular inflammation and atherosclerosis.

Journal: Nature metabolism

Published: October 02, 2019

Exploring immune checkpoints as potential therapeutic targets in atherosclerosis.

Exploring immune checkpoints as potential therapeutic targets in atherosclerosis.

Journal: Cardiovascular research

Published: September 08, 2017

Helminth antigens counteract a rapid high-fat diet-induced decrease in adipose tissue eosinophils.

Helminth antigens counteract a rapid high-fat diet-induced decrease in adipose tissue eosinophils.

Journal: Journal of molecular endocrinology

Published: July 06, 2017

Targeting CD40-Induced TRAF6 Signaling in Macrophages Reduces Atherosclerosis.

Targeting CD40-Induced TRAF6 Signaling in Macrophages Reduces Atherosclerosis.

Journal: Journal of the American College of Cardiology

Published: April 24, 2017

Showing 1-12 of 24

Last Updated: 09/26/2026